Breaking News

Aptiv Appoints Adaptive Trials Expert

March 21, 2013

Fardipour brings 23 years of experience

Parvin Fardipour, Ph.D. has been appointed vice president of Adaptive Clinical Trials at Aptiv Solutions. Dr. Fardipour will work with sponsors to identify opportunities for applying adaptive designs to their clinical trials to optimize study data. She has 23 years of experience managing adaptive trials in global pharmaceutical companies.
Most recently, Dr. Fardipour worked at Theorem Clinical Research as director of Global Statistical Programming, where she directed the successful execution of a Phase II/III combined study. Prior to Theorem, she spent 16 years at Wyeth, where she ultimately served as senior director of Adaptive Trials and Applied Program Strategies. 
“We are thrilled to have Parvin joining our team of adaptive clinical trials experts,” said Pat Donnelly, chairman and chief executive officer of Aptiv Solutions, “She brings unmatched experience to Aptiv Solutions having successfully designed and executed more than 20 adaptive trials during the past seven years.”
  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research